Assignee
GENECENTRIC THERAPEUTICS INC
US·9 granted patents·11 pending applications·15 citations·filing 2015–2023
Top patents by PatentIndex Score
20 records- 0188US11851715B2Detecting cancer cell of originGENECENTRIC THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·1 cites·7 claims
- 0286US10934595B2Methods for subtyping of lung adenocarcinomaGENECENTRIC THERAPEUTICS INC·Filed 2017·Granted Mar 2, 2021·4 cites·11 claims
- 0385US11739386B2Methods for determining response to PARP inhibitorsGENECENTRIC THERAPEUTICS INC·Filed 2018·Granted Aug 29, 2023·3 cites·9 claims
- 0482US12195805B2Methods for subtyping of bladder cancerGENECENTRIC THERAPEUTICS INC·Filed 2019·Granted Jan 14, 2025·2 cites·13 claims
- 0582US11041214B2Methods for subtyping of lung squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2017·Granted Jun 22, 2021·2 cites·14 claims
- 0681US10829819B2Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2015·Granted Nov 10, 2020·3 cites·15 claims
- 0774US2022243283A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0871US2022002820A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0970US2023395263A1Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment managementGENECENTRIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1068US2021147948A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1166US12139765B2Methods for subtyping of lung squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·0 cites·5 claims
- 1265US12139763B2Methods for subtyping of lung adenocarcinomaGENECENTRIC THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·0 cites·5 claims
- 1361US2021388449A1Detecting cancer cell of originGENECENTRIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1460US2019203296A1Methods for typing of lung cancerGENECENTRIC THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1557US2021074431A1Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment managementGENECENTRIC THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1654US2024182984A1Methods for assessing proliferation and anti-folate therapeutic responseGENECENTRIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1753US2025191689A1Methods for subtyping and treatment of head and neck squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1850US2023243813A1Methods for selecting and treating cancer with fgfr3 inhibitorsGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1949US2021398612A1Detecting tumor mutation burden with rna substrateGENECENTRIC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2044US12006554B2Methods for subtyping of head and neck squamous cell carcinomaGENECENTRIC THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2024·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when GENECENTRIC THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →